Published in Tissue Eng on May 01, 2006
Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl (2009) 3.09
Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering. Biomaterials (2009) 2.41
Engineering on the straight and narrow: the mechanics of nanofibrous assemblies for fiber-reinforced tissue regeneration. Tissue Eng Part B Rev (2009) 1.88
Novel nanofiber-based scaffold for rotator cuff repair and augmentation. Tissue Eng Part A (2009) 1.69
Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J (2008) 1.68
Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials (2007) 1.67
Controlling the porosity and microarchitecture of hydrogels for tissue engineering. Tissue Eng Part B Rev (2010) 1.61
Characterization of the complete fiber network topology of planar fibrous tissues and scaffolds. Biomaterials (2010) 1.51
Three-dimensional electrospun ECM-based hybrid scaffolds for cardiovascular tissue engineering. Biomaterials (2008) 1.48
Ultra Low Density and Highly Crosslinked Biocompatible Shape Memory Polyurethane Foams. J Polym Sci B Polym Phys (2012) 1.48
Nanofiber assembly by rotary jet-spinning. Nano Lett (2010) 1.45
Electrospun nanofibers for regenerative medicine. Adv Healthc Mater (2011) 1.44
An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials (2010) 1.42
Microporous dermal-mimetic electrospun scaffolds pre-seeded with fibroblasts promote tissue regeneration in full-thickness skin wounds. PLoS One (2015) 1.41
Review: advances in vascular tissue engineering using protein-based biomaterials. Tissue Eng (2007) 1.33
Complete recombinant silk-elastinlike protein-based tissue scaffold. Biomacromolecules (2010) 1.30
Sacrificial nanofibrous composites provide instruction without impediment and enable functional tissue formation. Proc Natl Acad Sci U S A (2012) 1.23
Computational predictions of the tensile properties of electrospun fibre meshes: effect of fibre diameter and fibre orientation. J Mech Behav Biomed Mater (2008) 1.22
Cell colonization in degradable 3D porous matrices. Cell Adh Migr (2008) 1.22
Myogenic Induction of Aligned Mesenchymal Stem Cell Sheets by Culture on Thermally Responsive Electrospun Nanofibers. Adv Mater (2007) 1.20
Polymers to direct cell fate by controlling the microenvironment. Curr Opin Biotechnol (2007) 1.20
Biomaterials for vascular tissue engineering. Regen Med (2010) 1.19
Cell infiltration and growth in a low density, uncompressed three-dimensional electrospun nanofibrous scaffold. Biomaterials (2010) 1.18
Bioactive electrospun scaffolds delivering growth factors and genes for tissue engineering applications. Pharm Res (2010) 1.18
Polypyrrole-coated electrospun PLGA nanofibers for neural tissue applications. Biomaterials (2009) 1.18
Degradable polyester scaffolds with controlled surface chemistry combining minimal protein adsorption with specific bioactivation. Nat Mater (2011) 1.15
Novel strategies in tendon and ligament tissue engineering: Advanced biomaterials and regeneration motifs. Sports Med Arthrosc Rehabil Ther Technol (2010) 1.14
Functional attachment of soft tissues to bone: development, healing, and tissue engineering. Annu Rev Biomed Eng (2013) 1.14
Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infiltration. Biomaterials (2011) 1.11
Tissue engineering strategies for the regeneration of orthopedic interfaces. Ann Biomed Eng (2010) 1.10
Quantitative analysis of complex glioma cell migration on electrospun polycaprolactone using time-lapse microscopy. Tissue Eng Part C Methods (2009) 1.08
Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med (2012) 1.08
Functional cardiac tissue engineering. Regen Med (2012) 1.07
Mesenchymal stem cell responses to bone-mimetic electrospun matrices composed of polycaprolactone, collagen I and nanoparticulate hydroxyapatite. PLoS One (2011) 1.05
Hydrogel scaffolds for tissue engineering: Progress and challenges. Glob Cardiol Sci Pract (2013) 1.05
On the biomechanical function of scaffolds for engineering load-bearing soft tissues. Acta Biomater (2010) 1.04
Optimization strategies for electrospun silk fibroin tissue engineering scaffolds. Biomaterials (2009) 1.03
Orthopedic interface tissue engineering for the biological fixation of soft tissue grafts. Clin Sports Med (2009) 1.03
Polymeric nanofibers in tissue engineering. Tissue Eng Part B Rev (2011) 1.03
Characterization of electrospun nanocomposite scaffolds and biocompatibility with adipose-derived human mesenchymal stem cells. Int J Nanomedicine (2007) 1.01
Electrospinning of small diameter 3-D nanofibrous tubular scaffolds with controllable nanofiber orientations for vascular grafts. J Mater Sci Mater Med (2010) 0.99
Enhanced polarization of embryonic hippocampal neurons on micron scale electrospun fibers. J Biomed Mater Res A (2010) 0.99
The development of collagen-GAG scaffold-membrane composites for tendon tissue engineering. Biomaterials (2011) 0.98
Biomimetic scaffold design for functional and integrative tendon repair. J Shoulder Elbow Surg (2012) 0.97
Radially aligned, electrospun nanofibers as dural substitutes for wound closure and tissue regeneration applications. ACS Nano (2010) 0.95
Delivery of platelet-derived growth factor as a chemotactic factor for mesenchymal stem cells by bone-mimetic electrospun scaffolds. PLoS One (2012) 0.94
Bone tissue engineering scaffolding: computer-aided scaffolding techniques. Prog Biomater (2014) 0.93
Engineering of arteries in vitro. Cell Mol Life Sci (2014) 0.92
Localized delivery of dexamethasone from electrospun fibers reduces the foreign body response. Biomacromolecules (2012) 0.91
Gradients with depth in electrospun fibrous scaffolds for directed cell behavior. Biomacromolecules (2011) 0.90
Nanofibrous membrane of collagen-polycaprolactone for cell growth and tissue regeneration. J Mater Sci Mater Med (2009) 0.90
Mechanical property characterization of electrospun recombinant human tropoelastin for vascular graft biomaterials. Acta Biomater (2011) 0.90
Tailored fibro-porous structure of electrospun polyurethane membranes, their size-dependent properties and trans-membrane glucose diffusion. J Memb Sci (2013) 0.89
Nanofibrous scaffolds in biomedical applications. Biomater Res (2014) 0.89
Femtosecond laser ablation enhances cell infiltration into three-dimensional electrospun scaffolds. Acta Biomater (2012) 0.89
Colonization and osteogenic differentiation of different stem cell sources on electrospun nanofiber meshes. Tissue Eng Part A (2010) 0.89
Dose effect of tumor necrosis factor-alpha on in vitro osteogenic differentiation of mesenchymal stem cells on biodegradable polymeric microfiber scaffolds. Biomaterials (2009) 0.89
Preparation of poly(ethylene glycol)/polylactide hybrid fibrous scaffolds for bone tissue engineering. Int J Nanomedicine (2011) 0.89
Neurite outgrowth on electrospun nanofibers with uniaxial alignment: the effects of fiber density, surface coating, and supporting substrate. ACS Nano (2014) 0.89
Cellular response of limbal epithelial cells on electrospun poly-ε-caprolactone nanofibrous scaffolds for ocular surface bioengineering: a preliminary in vitro study. Mol Vis (2011) 0.88
Effect of substrate composition and alignment on corneal cell phenotype. Tissue Eng Part A (2010) 0.88
Injectable polyHIPEs as high-porosity bone grafts. Biomacromolecules (2011) 0.88
Chitosan-based scaffolds for bone tissue engineering. J Mater Chem B Mater Biol Med (2014) 0.88
Nanofiber matrices promote the neuronal differentiation of human embryonic stem cell-derived neural precursors in vitro. Tissue Eng Part A (2010) 0.87
Spray deposition of live cells throughout the electrospinning process produces nanofibrous three-dimensional tissue scaffolds. Int J Nanomedicine (2011) 0.87
Electrospinning jets and nanofibrous structures. Biomicrofluidics (2011) 0.87
An amphiphilic degradable polymer/hydroxyapatite composite with enhanced handling characteristics promotes osteogenic gene expression in bone marrow stromal cells. Acta Biomater (2013) 0.86
Patterning of polymer nanofiber meshes by electrospinning for biomedical applications. Int J Nanomedicine (2007) 0.86
Elastase-sensitive elastomeric scaffolds with variable anisotropy for soft tissue engineering. Pharm Res (2008) 0.86
Current strategies for sustaining drug release from electrospun nanofibers. J Control Release (2015) 0.85
Stimulated myoblast differentiation on graphene oxide-impregnated PLGA-collagen hybrid fibre matrices. J Nanobiotechnology (2015) 0.85
Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications. Tissue Eng Part B Rev (2014) 0.85
Anisotropic poly(ethylene glycol)/polycaprolactone hydrogel-fiber composites for heart valve tissue engineering. Tissue Eng Part A (2014) 0.85
Electrospun vascular grafts with improved compliance matching to native vessels. J Biomed Mater Res B Appl Biomater (2014) 0.85
Bioreactor design for tendon/ligament engineering. Tissue Eng Part B Rev (2012) 0.85
Electrospun polycaprolactone scaffolds with tailored porosity using two approaches for enhanced cellular infiltration. J Mater Sci Mater Med (2012) 0.85
Control of surface chemistry, substrate stiffness, and cell function in a novel terpolymer methacrylate library. Langmuir (2011) 0.85
Next generation of electrosprayed fibers for tissue regeneration. Tissue Eng Part B Rev (2011) 0.84
Use of an insulating mask for controlling anisotropy in multilayer electrospun scaffolds for tissue engineering. J Mater Chem (2010) 0.84
Electrospun fibrous scaffolds promote breast cancer cell alignment and epithelial-mesenchymal transition. Langmuir (2011) 0.84
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
Biomimetic engineering of nanofibrous gelatin scaffolds with noncollagenous proteins for enhanced bone regeneration. Tissue Eng Part A (2013) 0.83
Neurite outgrowth on electrospun PLLA fibers is enhanced by exogenous electrical stimulation. J Neural Eng (2014) 0.83
A novel in vitro model for microvasculature reveals regulation of circumferential ECM organization by curvature. PLoS One (2013) 0.82
Micro/nano-fabrication technologies for cell biology. Med Biol Eng Comput (2010) 0.82
Integrated micro/nanoengineered functional biomaterials for cell mechanics and mechanobiology: a materials perspective. Adv Mater (2013) 0.82
Novel opportunities and challenges offered by nanobiomaterials in tissue engineering. Int J Nanomedicine (2008) 0.82
Electrospinning of novel biodegradable poly(ester urethane)s and poly(ester urethane urea)s for soft tissue-engineering applications. J Mater Sci Mater Med (2009) 0.82
Nerve guidance conduits based on double-layered scaffolds of electrospun nanofibers for repairing the peripheral nervous system. ACS Appl Mater Interfaces (2014) 0.81
Form Follows Function: Advances in Trilayered Structure Replication for Aortic Heart Valve Tissue Engineering. J Healthc Eng (2012) 0.81
Incorporation of functionalized gold nanoparticles into nanofibers for enhanced attachment and differentiation of mammalian cells. J Nanobiotechnology (2012) 0.81
Nanofiber scaffolds with gradients in mineral content for spatial control of osteogenesis. ACS Appl Mater Interfaces (2014) 0.81
The role of biodegradable engineered nanofiber scaffolds seeded with hair follicle stem cells for tissue engineering. Iran Biomed J (2012) 0.81
Textile Technologies and Tissue Engineering: A Path Toward Organ Weaving. Adv Healthc Mater (2016) 0.81
Nanofiber orientation and surface functionalization modulate human mesenchymal stem cell behavior in vitro. Tissue Eng Part A (2013) 0.81
Generation of electrospun nanofibers with controllable degrees of crimping through a simple, plasticizer-based treatment. Adv Mater (2015) 0.81
Emulsion electrospinning as an approach to fabricate PLGA/chitosan nanofibers for biomedical applications. Biomed Res Int (2014) 0.80
Effect of temporally patterned TNF-α delivery on in vitro osteogenic differentiation of mesenchymal stem cells cultured on biodegradable polymer scaffolds. J Biomater Sci Polym Ed (2013) 0.80
Airbrushed composite polymer Zr-ACP nanofiber scaffolds with improved cell penetration for bone tissue regeneration. Tissue Eng Part C Methods (2014) 0.80
Laminin Functionalized Biomimetic Nanofibers For Nerve Tissue Engineering. J Biomater Tissue Eng (2013) 0.80
Electrospun poly(epsilon-caprolactone) microfiber and multilayer nanofiber/microfiber scaffolds: characterization of scaffolds and measurement of cellular infiltration. Biomacromolecules (2006) 3.01
Biomimetic materials for tissue engineering. Biomaterials (2003) 2.87
Strategic directions in tissue engineering. Tissue Eng (2007) 2.70
Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci U S A (2003) 2.42
Gelatin as a delivery vehicle for the controlled release of bioactive molecules. J Control Release (2005) 2.32
Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm (2007) 2.25
Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proc Natl Acad Sci U S A (2002) 2.24
Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone (2008) 2.19
In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proc Natl Acad Sci U S A (2006) 2.03
Donor age and cell passage affects differentiation potential of murine bone marrow-derived stem cells. BMC Cell Biol (2008) 2.00
Injectable matrices and scaffolds for drug delivery in tissue engineering. Adv Drug Deliv Rev (2007) 1.97
Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev (2008) 1.92
Tissue engineering of bone: material and matrix considerations. J Bone Joint Surg Am (2008) 1.91
Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials (2005) 1.85
Tissue engineering strategies for bone regeneration. Adv Biochem Eng Biotechnol (2005) 1.80
Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Eng (2003) 1.79
Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials (2007) 1.78
Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release (2005) 1.68
Fabrication of porous ultra-short single-walled carbon nanotube nanocomposite scaffolds for bone tissue engineering. Biomaterials (2007) 1.67
Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A (2009) 1.67
Delivery of TGF-beta1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials (2005) 1.63
Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A (2005) 1.61
Injectable biomaterials for regenerating complex craniofacial tissues. Adv Mater (2009) 1.60
Use of stereolithography to manufacture critical-sized 3D biodegradable scaffolds for bone ingrowth. J Biomed Mater Res B Appl Biomater (2003) 1.59
Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J Biomed Mater Res A (2005) 1.58
Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev (2012) 1.57
Engineering complex tissues. Sci Transl Med (2012) 1.54
Photocrosslinking characteristics and mechanical properties of diethyl fumarate/poly(propylene fumarate) biomaterials. Biomaterials (2002) 1.52
In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. J Control Release (2003) 1.52
Nanobiomaterial applications in orthopedics. J Orthop Res (2007) 1.51
Evaluation of bone regeneration using the rat critical size calvarial defect. Nat Protoc (2012) 1.51
Effect of initial cell seeding density on early osteogenic signal expression of rat bone marrow stromal cells cultured on cross-linked poly(propylene fumarate) disks. Biomacromolecules (2009) 1.48
Bioactive poly(L-lactic acid) conduits seeded with Schwann cells for peripheral nerve regeneration. Biomaterials (2002) 1.47
Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res (2002) 1.46
Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. J Control Release (2004) 1.45
Thermally cross-linked oligo(poly(ethylene glycol) fumarate) hydrogels support osteogenic differentiation of encapsulated marrow stromal cells in vitro. Biomacromolecules (2004) 1.45
Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater (2008) 1.43
Osteogenic differentiation of mesenchymal stem cells on pregenerated extracellular matrix scaffolds in the absence of osteogenic cell culture supplements. Tissue Eng Part A (2010) 1.38
Harnessing and modulating inflammation in strategies for bone regeneration. Tissue Eng Part B Rev (2011) 1.37
In vivo biocompatibility of ultra-short single-walled carbon nanotube/biodegradable polymer nanocomposites for bone tissue engineering. Bone (2008) 1.35
Review: mineralization of synthetic polymer scaffolds for bone tissue engineering. Tissue Eng (2007) 1.35
Effect of poly(ethylene glycol) molecular weight on tensile and swelling properties of oligo(poly(ethylene glycol) fumarate) hydrogels for cartilage tissue engineering. J Biomed Mater Res (2002) 1.34
Pre-culture period of mesenchymal stem cells in osteogenic media influences their in vivo bone forming potential. J Biomed Mater Res A (2007) 1.34
In vitro osteogenic differentiation of marrow stromal cells encapsulated in biodegradable hydrogels. J Biomed Mater Res A (2004) 1.32
Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. J Biomed Mater Res (2002) 1.31
Kinetics of poly(propylene fumarate) synthesis by step polymerization of diethyl fumarate and propylene glycol using zinc chloride as a catalyst. J Biomater Sci Polym Ed (2002) 1.30
Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Ann Biomed Eng (2005) 1.29
In vitro cytotoxicity of injectable and biodegradable poly(propylene fumarate)-based networks: unreacted macromers, cross-linked networks, and degradation products. Biomacromolecules (2003) 1.29
The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials (2008) 1.29
Modeling Ewing sarcoma tumors in vitro with 3D scaffolds. Proc Natl Acad Sci U S A (2013) 1.23
Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Eng (2006) 1.23
Injectable nanocomposites of single-walled carbon nanotubes and biodegradable polymers for bone tissue engineering. Biomacromolecules (2006) 1.23
Modulation of differentiation and mineralization of marrow stromal cells cultured on biomimetic hydrogels modified with Arg-Gly-Asp containing peptides. J Biomed Mater Res A (2004) 1.22
Modulation of marrow stromal osteoblast adhesion on biomimetic oligo[poly(ethylene glycol) fumarate] hydrogels modified with Arg-Gly-Asp peptides and a poly(ethyleneglycol) spacer. J Biomed Mater Res (2002) 1.22
Angiogenesis with biomaterial-based drug- and cell-delivery systems. J Biomater Sci Polym Ed (2004) 1.21
In vitro and in vivo release of vascular endothelial growth factor from gelatin microparticles and biodegradable composite scaffolds. Pharm Res (2008) 1.21
Modulation of osteogenic properties of biodegradable polymer/extracellular matrix scaffolds generated with a flow perfusion bioreactor. Acta Biomater (2010) 1.21
Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater (2009) 1.21
Synthesis of poly(propylene fumarate). Nat Protoc (2009) 1.20
Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch-based three-dimensional scaffolds. J Biomed Mater Res A (2003) 1.20
In vivo bone and soft tissue response to injectable, biodegradable oligo(poly(ethylene glycol) fumarate) hydrogels. Biomaterials (2003) 1.19
Engineering tumors: a tissue engineering perspective in cancer biology. Tissue Eng Part B Rev (2010) 1.19
Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A (2009) 1.18
Effect of swelling ratio of injectable hydrogel composites on chondrogenic differentiation of encapsulated rabbit marrow mesenchymal stem cells in vitro. Biomacromolecules (2009) 1.18
Synthesis and characterization of injectable, thermally and chemically gelable, amphiphilic poly(N-isopropylacrylamide)-based macromers. Biomacromolecules (2008) 1.18
Osteogenic differentiation of rat bone marrow stromal cells cultured on Arg-Gly-Asp modified hydrogels without dexamethasone and beta-glycerol phosphate. Biomaterials (2005) 1.17
Enhanced chondrogenesis in co-cultures with articular chondrocytes and mesenchymal stem cells. Biomaterials (2012) 1.17
Bioactive polymer/extracellular matrix scaffolds fabricated with a flow perfusion bioreactor for cartilage tissue engineering. Biomaterials (2010) 1.16
In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Eng (2006) 1.15
In vitro generation of an osteochondral construct using injectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials (2009) 1.13
Attachment, proliferation, and migration of marrow stromal osteoblasts cultured on biomimetic hydrogels modified with an osteopontin-derived peptide. Biomaterials (2004) 1.13
Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects. Tissue Eng Part A (2010) 1.12
Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage (2005) 1.11
Two-dimensional nanostructure-reinforced biodegradable polymeric nanocomposites for bone tissue engineering. Biomacromolecules (2013) 1.11
In vitro degradation of polymeric networks of poly(propylene fumarate) and the crosslinking macromer poly(propylene fumarate)-diacrylate. Biomaterials (2003) 1.11
The effect of hypoxia on the chondrogenic differentiation of co-cultured articular chondrocytes and mesenchymal stem cells in scaffolds. Biomaterials (2013) 1.10
Synthesis of oligo(poly(ethylene glycol) fumarate). Nat Protoc (2012) 1.09
Gadofullerenes as nanoscale magnetic labels for cellular MRI. Contrast Media Mol Imaging (2007) 1.09
Flow perfusion culture of marrow stromal osteoblasts in titanium fiber mesh. J Biomed Mater Res A (2003) 1.09
Bone response and mechanical strength of rabbit femoral defects filled with injectable CaP cements containing TGF-beta 1 loaded gelatin microparticles. Biomaterials (2007) 1.08
Osteochondral tissue regeneration using a bilayered composite hydrogel with modulating dual growth factor release kinetics in a rabbit model. J Control Release (2013) 1.08
In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. Biomaterials (2005) 1.08
Fibrin glue as a drug delivery system. J Control Release (2010) 1.08
Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue-engineered constructs using a rat cranial critical size defect model. J Biomed Mater Res A (2003) 1.08
The influence of stereolithographic scaffold architecture and composition on osteogenic signal expression with rat bone marrow stromal cells. Biomaterials (2011) 1.07
rhBMP-2 release from injectable poly(DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am (2003) 1.07
Scaffold mesh size affects the osteoblastic differentiation of seeded marrow stromal cells cultured in a flow perfusion bioreactor. J Biomed Mater Res A (2005) 1.06
Regulated non-viral gene delivery from coaxial electrospun fiber mesh scaffolds. J Control Release (2009) 1.06
Porous poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composite for reconstruction of bone defects. Tissue Eng (2006) 1.06
Structure-property evaluation of thermally and chemically gelling injectable hydrogels for tissue engineering. Biomacromolecules (2012) 1.06
Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part I. Determination of network structure. Biomacromolecules (2003) 1.06
Injectable in situ cross-linkable nanocomposites of biodegradable polymers and carbon nanostructures for bone tissue engineering. J Biomater Sci Polym Ed (2007) 1.05
Early osteogenic signal expression of rat bone marrow stromal cells is influenced by both hydroxyapatite nanoparticle content and initial cell seeding density in biodegradable nanocomposite scaffolds. Acta Biomater (2010) 1.05
In vitro cytotoxicity of redox radical initiators for cross-linking of oligo(poly(ethylene glycol) fumarate) macromers. Biomacromolecules (2003) 1.05
Biocompatibility and degradation of poly(DL-lactic-co-glycolic acid)/calcium phosphate cement composites. J Biomed Mater Res A (2005) 1.05
Photoinitiated cross-linking of the biodegradable polyester poly(propylene fumarate). Part II. In vitro degradation. Biomacromolecules (2003) 1.05
The kinetic and biological activity of different loaded rhBMP-2 calcium phosphate cement implants in rats. J Biomed Mater Res A (2008) 1.04
In vivo bone biocompatibility and degradation of porous fumarate-based polymer/alumoxane nanocomposites for bone tissue engineering. J Biomed Mater Res A (2010) 1.04